RxDoctor Payments Data

Sandeep Soni

Pediatric Hematology-Oncology · Palo Alto, CANPI 1104807718

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,140 of the $2,207 with a category attached, or 96.9%. Vertex accounts for 96.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $2,140 and has fallen 99.2% since, to $18 in 2025.

$2,207in general payments, 2019–2025

Across 4 payments — averaging $551.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$2K
  • Shionogi Inc$37
  • Gilead$31
$1,423,345in research payments, 2019–2025

Across 6 payments — averaging $237,224 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$1.4M

What the payments were for

  • Consulting fees$2,14097%
  • Food & beverage$673%

General payments by program year

19
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertex1$2,140
Shionogi Inc2$37
Gilead1$31

How this compares

$2,207 in reported general payments places this provider in the 60th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California

Other pediatric hematology-oncology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →